| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Professional Issues Articles
Scientists are considering a two-pronged approach of having the body copy existing beta cells that are still functional while the pancreas is simultaneously induced to produce entirely new ones.
Researchers funded by the Juvenile Diabetes Research Foundation have found two chemical compounds that can trigger the growth of insulin-producing beta cells in the pancreas. The discovery could become the basis for medicines designed to regenerate the pancreas in people with type 1 diabetes.
The JDRF-sponsored team at the Genomics Institute of the Novartis Research Foundation screened a vast library of chemical compounds-more than 850,000-to see what effects they might have on triggering the production of new beta cells lines derived from mice.
The researchers found 80 compounds that merited further investigation and eventually focused on two. One compound promotes beta cell replication by means of a biological pathway that is critical to beta cell development in embryos. The other uses an ion channel, which regulates the flow of ions across cell membranes, to induce beta cell proliferation.
The next step will be to conduct studies on animals to see if the compounds' effects can be replicated in a whole organism. If that line of research pans out, the hope is to test the compounds on humans.
The Novartis study continues the JDRF's focus on research into making the body re-grow beta cells that have been killed by the autoimmune effects of type 1 diabetes. They are considering a two-pronged approach of having the body copy existing beta cells that are still functional while the pancreas is simultaneously induced to produce entirely new ones.
The study was published in the Proceedings of the National Academy of Sciences.
Categories: Beta Cells, Insulin, Medications Research, Professional Issues, Type 1 Issues
9 comments -
Mar 11, 2009 -
Email to a Friend
Send a link to this page to your friends and colleagues.